NL7301975A - - Google Patents

Info

Publication number
NL7301975A
NL7301975A NL7301975A NL7301975A NL7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A
Authority
NL
Netherlands
Application number
NL7301975A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7301975A publication Critical patent/NL7301975A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7301975A 1972-02-11 1973-02-12 NL7301975A (US20020193084A1-20021219-M00002.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207420A DE2207420A1 (de) 1972-02-11 1972-02-11 Verfahren zur herstellung von 16,17ungesaettigten steroiden

Publications (1)

Publication Number Publication Date
NL7301975A true NL7301975A (US20020193084A1-20021219-M00002.png) 1973-08-14

Family

ID=5836210

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7301975A NL7301975A (US20020193084A1-20021219-M00002.png) 1972-02-11 1973-02-12

Country Status (15)

Country Link
US (1) US3842105A (US20020193084A1-20021219-M00002.png)
JP (1) JPS4886854A (US20020193084A1-20021219-M00002.png)
AT (1) AT328102B (US20020193084A1-20021219-M00002.png)
AU (1) AU468856B2 (US20020193084A1-20021219-M00002.png)
BE (1) BE795243A (US20020193084A1-20021219-M00002.png)
CH (1) CH586719A5 (US20020193084A1-20021219-M00002.png)
CS (1) CS165381B2 (US20020193084A1-20021219-M00002.png)
DD (1) DD100942A5 (US20020193084A1-20021219-M00002.png)
DE (1) DE2207420A1 (US20020193084A1-20021219-M00002.png)
DK (1) DK131942C (US20020193084A1-20021219-M00002.png)
FR (1) FR2171374B1 (US20020193084A1-20021219-M00002.png)
GB (1) GB1424212A (US20020193084A1-20021219-M00002.png)
HU (1) HU165442B (US20020193084A1-20021219-M00002.png)
NL (1) NL7301975A (US20020193084A1-20021219-M00002.png)
SE (1) SE385591B (US20020193084A1-20021219-M00002.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216159A (en) * 1978-05-25 1980-08-05 The Upjohn Company Synthesis of 16-unsaturated pregnanes from 17-keto steroids
EP0306969B1 (en) * 1987-09-11 1994-11-30 Nippon Zeon Co., Ltd. A process for producing an alpha-acyloxy-alpha beta-unsaturated carbonyl compound and a 20-acyl-oxy-17(20)-methylen-21-al-steroid compound
US5169966A (en) * 1987-09-11 1992-12-08 Nippon Zeon Co., Ltd Process for producing an α-acyloxy-α, β-unsaturated carbonyl compound and a 20-acyloxy-17(20)-methylen-21-al-steroid compound
EP3656385A1 (en) 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of nf-kb for treatment of disease
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
CN102603843B (zh) * 2012-02-20 2013-07-31 湖南诺凯生物医药有限公司 一种地塞米松中间体的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
FR2171374B1 (US20020193084A1-20021219-M00002.png) 1976-06-11
CH586719A5 (US20020193084A1-20021219-M00002.png) 1977-04-15
GB1424212A (en) 1976-02-11
FR2171374A1 (US20020193084A1-20021219-M00002.png) 1973-09-21
DD100942A5 (US20020193084A1-20021219-M00002.png) 1973-10-12
DK131942B (da) 1975-09-29
BE795243A (fr) 1973-08-09
AU5193173A (en) 1974-08-08
SE385591B (sv) 1976-07-12
CS165381B2 (US20020193084A1-20021219-M00002.png) 1975-12-22
HU165442B (US20020193084A1-20021219-M00002.png) 1974-08-28
ATA112373A (de) 1975-05-15
JPS4886854A (US20020193084A1-20021219-M00002.png) 1973-11-15
DE2207420A1 (de) 1973-08-16
AU468856B2 (en) 1976-01-22
DK131942C (da) 1976-02-23
AT328102B (de) 1976-03-10
US3842105A (en) 1974-10-15

Similar Documents

Publication Publication Date Title
FR2193692B1 (US20020193084A1-20021219-M00002.png)
JPS4916022A (US20020193084A1-20021219-M00002.png)
FR2171374B1 (US20020193084A1-20021219-M00002.png)
JPS497802A (US20020193084A1-20021219-M00002.png)
JPS4833441A (US20020193084A1-20021219-M00002.png)
JPS4876841A (US20020193084A1-20021219-M00002.png)
JPS4884149A (US20020193084A1-20021219-M00002.png)
JPS4725469U (US20020193084A1-20021219-M00002.png)
JPS4894124A (US20020193084A1-20021219-M00002.png)
JPS4951196A (US20020193084A1-20021219-M00002.png)
JPS5224327Y2 (US20020193084A1-20021219-M00002.png)
JPS5247363Y2 (US20020193084A1-20021219-M00002.png)
CS152691B1 (US20020193084A1-20021219-M00002.png)
CS152731B1 (US20020193084A1-20021219-M00002.png)
CS151664B1 (US20020193084A1-20021219-M00002.png)
CS152532B1 (US20020193084A1-20021219-M00002.png)
CS152699B1 (US20020193084A1-20021219-M00002.png)
CH587276A5 (US20020193084A1-20021219-M00002.png)
CH559598A5 (US20020193084A1-20021219-M00002.png)
CH587518A5 (US20020193084A1-20021219-M00002.png)
BG20645A1 (US20020193084A1-20021219-M00002.png)
AU936672A (US20020193084A1-20021219-M00002.png)
CH567780A5 (US20020193084A1-20021219-M00002.png)
BG17676A1 (US20020193084A1-20021219-M00002.png)
CH441173A4 (US20020193084A1-20021219-M00002.png)

Legal Events

Date Code Title Description
BV The patent application has lapsed